Cargando…

Therapeutic Effect and Mechanism of Si-Miao-Yong-An-Tang on Thromboangiitis Obliterans Based on the Urine Metabolomics Approach

Si-Miao-Yong-An-Tang (SMYAT) is a classic prescription for the treatment of thromboangiitis obliterans (TAO). However, the effect and mechanism are still unclear. This experiment aims to evaluate the therapeutic effect and mechanism of SMYAT on sodium laurate solution induced thromboangiitis obliter...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Hui-Yu, Sun, Hui, Zhang, Ai-Hua, He, Lu-Wen, Qiu, Shi, Xue, Jun-Ru, Wu, Fangfang, Wang, Xi-Jun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Pharmacology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8902467/ https://www.ncbi.nlm.nih.gov/pubmed/35273504 http://dx.doi.org/10.3389/fphar.2022.827733

Ejemplares similares

Network pharmacology-based approach to research the effect and mechanism of Si-Miao-Yong-An decoction against thromboangiitis obliterans
por: Zou, Jiaxi, et al.
Publicado: (2023)

Si-Miao-Yong-An Decoction Protects Against Cardiac Hypertrophy and Dysfunction by Inhibiting Platelet Aggregation and Activation
por: Su, Congping, et al.
Publicado: (2019)

Si-Miao-Yong-An Decoction for Diabetic Retinopathy: A Combined Network Pharmacological and In Vivo Approach
por: Du, Ao, et al.
Publicado: (2021)

Si-Miao-Yong-An (SMYA) Decoction May Protect the Renal Function Through Regulating the Autophagy-Mediated Degradation of Ubiquitinated Protein in an Atherosclerosis Model
por: Zhu, Ze-Bing, et al.
Publicado: (2020)

Effect and Mechanism of Si-Miao-Yong-An on Vasa Vasorum Remodeling in ApoE(−/−) Mice with Atherosclerosis Vulnerable Plague
por: Li, Meng, et al.
Publicado: (2021)

Thromboangiitis Obliterans
Publicado: (1953)

Thromboangiitis obliterans (Buerger's disease)
por: Arkkila, Perttu ET
Publicado: (2006)

Thromboangiitis obliterans (Buerger's disease)
por: Rivera-Chavarría, Ignacio J., et al.
Publicado: (2016)

Thromboangiitis Obliterans (Buerger's Disease)
por: Sinclair, Nicholas R., et al.
Publicado: (2015)

Thromboangiitis obliterans in two brothers
por: LI, QI-LIN, et al.
Publicado: (2013)

Thromboangiitis obliterans (Buerger disease)
por: Seebald, Jessica, et al.
Publicado: (2015)

Long-term outcomes of large artery thromboangiitis obliterans and comparison with small artery thromboangiitis obliterans
por: Lee, Sang Ah, et al.
Publicado: (2022)

Jia-Wei-Si-Miao-Yong-An decoction modulates intestinal flora and metabolites in acute coronary syndrome model
por: Zhao, Ning, et al.
Publicado: (2023)

Therapeutic Effects of Modified Si-Miao-Yong-An Decoction in the Treatment of Rat Myocardial Ischemia/Reperfusion Injury
por: Wang, Chen, et al.
Publicado: (2022)

Si-Miao-Yong-An Decoction Maintains the Cardiac Function and Protects Cardiomyocytes from Myocardial Ischemia and Reperfusion Injury
por: Cui, Wenwen, et al.
Publicado: (2021)

Treatment of thromboangiitis obliterans (Buerger's disease) with bosentan
por: De Haro, Joaquin, et al.
Publicado: (2012)

Circulating Angiogenic Factors in Patients with Thromboangiitis Obliterans
por: Hewing, Bernd, et al.
Publicado: (2012)

Thromboangiitis Obliterans (Buerger's Disease)—Current Practices
por: Vijayakumar, Abhishek, et al.
Publicado: (2013)

Intestinal thromboangiitis obliterans: a case report
por: Mishra, Swastik Sourav, et al.
Publicado: (2021)

Effects of aspirin combined with cilostazol on thromboangiitis obliterans in diabetic patients
por: Yong, Jun, et al.
Publicado: (2018)

Exploring the Effect and Mechanism of Si-Miao-Yong-An Decoction on Abdominal Aortic Aneurysm Based on Mice Experiment and Bioinformatics Analysis
por: Xu, Zhenyu, et al.
Publicado: (2022)

Baiying qingmai formulation ameliorates thromboangiitis obliterans by inhibiting HMGB1/RAGE/NF-κB signaling pathways
por: Zou, Chongchong, et al.
Publicado: (2022)

Thromboangiitis Obliterans: Changing Demographics for a Preventable Disease
por: Stefancik, Ryan
Publicado: (2019)

Thromboangiitis obliterans episode: autoimmune flare-up or reinfection?
por: Mohareri, Mehran, et al.
Publicado: (2018)

Assessment of T helper 17-associated cytokines in thromboangiitis obliterans
por: Keramat, Shayan, et al.
Publicado: (2019)

Cerebral venous and sinus thrombosis with complicating thromboangiitis obliterans
por: Einsiedler, Stefan, et al.
Publicado: (2021)

Clinical Presentation and Treatment of Thromboangiitis Obliterans With Superimposed Osteomyelitis
por: Kidron, Ariel, et al.
Publicado: (2022)

The role of folic acid on the hyperhomocysteinemia in the Buerger's disease (Thromboangiitis Obliterans)
por: Beigi, Ali Akbar, et al.
Publicado: (2014)

Thromboangiitis Obliterans: 110 Years Old and Little Progress Made
por: Olin, Jeffrey W.
Publicado: (2018)

Visceral bed involvement in thromboangiitis obliterans: a systematic review
por: Fakour, Faeze, et al.
Publicado: (2019)

Retinal Artery Occlusion Secondary to Buerger's Disease (Thromboangiitis Obliterans)
por: Eris, Erdem, et al.
Publicado: (2017)

The IL-33/sST2 Axis in Thromboangiitis Obliterans
por: Sharebiani, Hiva, et al.
Publicado: (2020)

Buerger's Disease in the Testicle: A Case of Testicular Thromboangiitis Obliterans
por: Harwood, Emma A, et al.
Publicado: (2023)

Atypical Young-onset Dementia in Cerebral Thromboangiitis Obliterans: A Case Report
por: Kim, Eun-Joo, et al.
Publicado: (2022)

Predictive value of serum VEGF, IL-1 and TNF-α in the treatment of thromboangiitis obliterans by revascularization
por: Li, Zheng-Fei, et al.
Publicado: (2020)

Management of thromboangiitis obliterans using distraction osteogenesis: A retrospective study
por: Kulkarni, Sunil, et al.
Publicado: (2011)

Management of thromboangiitis obliterans using distraction osteogenesis: A retrospective study
por: Marwah, Vikram
Publicado: (2012)

Effect of revascularization on IL-6 and TNF-α in patients with thromboangiitis obliterans
por: Wu, Shifeng, et al.
Publicado: (2018)

Psychiatric sequelae of thromboangiitis obliterans: a case report and review of the literature
por: Awara, Mahmoud A., et al.
Publicado: (2023)

Early Diagnosis and Intervention Are Needed for a Reasonable Prognosis of Thromboangiitis Obliterans
por: Bae, Miju, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_511kt66riofpgfnkgvcb80134v